Cutting Timelines & Enhancing Efficiency & Scalability to Deliver High-Quality DNA for Life Changing Therapies and Vaccines
Cutting-edge breakthroughs in DNA production, from high-yield plasmid manufacturing to next-generation cell-free platforms, are transforming how biopharma develops advanced vaccines and nucleic acid–based therapeutics. Organizations across the space are accelerating investment in technologies that enhance upstream fermentation efficiency, streamline downstream purification, and strengthen CMC frameworks for rapid, compliant scale-up.
The 3rd DNA Process Development & Manufacturing Summit arrives at this pivotal moment as the only meeting entirely focused on DNA process development and manufacturing, designed to immerse you in the applied learnings needed to drive the next wave of innovation in DNA production.
Delve into the latest approaches for optimizing plasmid design, boosting fermentation productivity, advancing purification, reducing impurities, building robust analytical and QC strategies, and aligning regulatory expectations from early development through commercial production. Explore how to unlock reproducibility, scalability, and cost-efficient GMP-grade DNA.
Unite with industry leaders such as Sanofi, Pfizer, GSK, Boehringer Ingelheim, GreenLight Biosciences, HDT Bio, and others, as well as innovative emerging players advancing new DNA formats and manufacturing technologies.
This is your premier meeting dedicated to exploring the full DNA manufacturing lifecycle, from upstream to downstream, process development to scale-up, and quality to regulatory alignment. Walk away with actionable insights, practical solutions, and new strategic partnerships to accelerate the delivery of high-quality DNA for tomorrow’s vaccines and therapies.
The combination of big pharma utilizing synthetic DNA in their processes together with CDMOs offering synthetic DNA manufacturing was particularly valuable. The discussions around regulatory aspects were also highly insightful
Scientist, BioNTech
It was great to be able to connect with industry experts and users in the pDNA field. Especially the discussions concerning regulatory strategies was very interesting
Principal Manager, CMC Project
Creating an event focused on a specific topic is very difficult. It was very impressive how the organization managed to put together a variety of topics within the pDNA field covering very well this area with top speakers. Therefore, professionally it was very fulfilling with several potential collaborations already in discussion.
Vaccine Bioprocessing & Research Fellow
Explore the Full Event Guide
- 18+ World-Class Speakers
- 3 Days of Exclusive Content Spanning the Full Lifecycle of DNA Development
- Unmatched Networking & Strategic Partnering Opportunities
- Focused Focused Community of Top Pharma & Biotech Companies
Official Partners
Attending Companies Include
Explore Related Events
Explore the 2026 Agenda
Catch the latest industry breakthroughs, emerging trends and exclusive insights through our dynamic roundtables and panel discussions.
Partner With Us
As the field rapidly expands, position yourself alongside leading solution providers to ensure your brand stands out as a premier choice amid growing competition.
Join Biopharma Experts
Engage in critical conversations with like-minded attendees from all stages of DNA production and build invaluable connections during dedicated networking sessions.